Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer

PURPOSE: Recent retrospective data suggest that brachytherapy (BT) boost may confer a cancer-specific survival benefit in radiation-managed high-risk prostate cancer. We sought to determine whether this survival benefit would extend to the recently defined favorable high-risk subgroup of prostate ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Muralidhar, Vinayak, Xiang, Michael, Orio, Peter F., Martin, Neil E., Beard, Clair J., Feng, Felix Y., Hoffman, Karen E., Nguyen, Paul L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793071/
https://www.ncbi.nlm.nih.gov/pubmed/26985191
http://dx.doi.org/10.5114/jcb.2016.58080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793071/
https://www.ncbi.nlm.nih.gov/pubmed/26985191
http://dx.doi.org/10.5114/jcb.2016.58080

Ejemplares similares